EP0730466A4 - Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites - Google Patents

Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Info

Publication number
EP0730466A4
EP0730466A4 EP94928067A EP94928067A EP0730466A4 EP 0730466 A4 EP0730466 A4 EP 0730466A4 EP 94928067 A EP94928067 A EP 94928067A EP 94928067 A EP94928067 A EP 94928067A EP 0730466 A4 EP0730466 A4 EP 0730466A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
inhibiting hepatocyte
hepatocyte invasion
sporozoites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94928067A
Other languages
German (de)
French (fr)
Other versions
EP0730466A1 (en
Inventor
Carla Cerami
Ute Frevert
Phetori Sinnis
Victor Nussenzweig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of EP0730466A1 publication Critical patent/EP0730466A1/en
Publication of EP0730466A4 publication Critical patent/EP0730466A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
EP94928067A 1993-09-10 1994-09-09 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites Withdrawn EP0730466A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11969493A 1993-09-10 1993-09-10
US119694 1993-09-10
PCT/US1994/010186 WO1995007094A1 (en) 1993-09-10 1994-09-09 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Publications (2)

Publication Number Publication Date
EP0730466A1 EP0730466A1 (en) 1996-09-11
EP0730466A4 true EP0730466A4 (en) 1999-04-14

Family

ID=22385814

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94928067A Withdrawn EP0730466A4 (en) 1993-09-10 1994-09-09 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Country Status (4)

Country Link
EP (1) EP0730466A4 (en)
AU (1) AU7724894A (en)
CA (1) CA2171562A1 (en)
WO (1) WO1995007094A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9266930B1 (en) 1993-03-05 2016-02-23 Epimmune Inc. Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
FR2840220A1 (en) * 2002-05-28 2003-12-05 Univ Paris Curie Inhibiting entry of malarial sporozoites into hepatocytes, useful for prevention of malaria, using an inhibitor of interaction between CD81 and Plasmodium-associated ligand
SG149058A1 (en) * 2003-12-19 2009-01-29 Seattle Biomedical Res Inst Live genetically attenuated malaria vaccine
US8168166B2 (en) 2003-12-19 2012-05-01 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432965A1 (en) * 1989-12-08 1991-06-19 Smithkline Beecham Corporation Malaria vaccine
EP0517182A1 (en) * 1991-06-03 1992-12-09 Mitsubishi Chemical Corporation Hepatocyte-growth agent
WO1993002704A1 (en) * 1991-07-31 1993-02-18 Institut Pasteur Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum
WO1993003057A1 (en) * 1991-07-31 1993-02-18 Institut Pasteur Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions
EP0578342A2 (en) * 1992-05-14 1994-01-12 W.R. Grace & Co.-Conn. Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor
WO1994006464A1 (en) * 1992-09-17 1994-03-31 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432965A1 (en) * 1989-12-08 1991-06-19 Smithkline Beecham Corporation Malaria vaccine
EP0517182A1 (en) * 1991-06-03 1992-12-09 Mitsubishi Chemical Corporation Hepatocyte-growth agent
WO1993002704A1 (en) * 1991-07-31 1993-02-18 Institut Pasteur Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum
WO1993003057A1 (en) * 1991-07-31 1993-02-18 Institut Pasteur Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions
EP0578342A2 (en) * 1992-05-14 1994-01-12 W.R. Grace & Co.-Conn. Purification and characterization of a CSVTCG-specific tumor cell adhesion receptor
WO1994006464A1 (en) * 1992-09-17 1994-03-31 New York University Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CERAMI, CARLA ET AL: "The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites", CELL (CAMBRIDGE, MASS.) (1992), 70(6), 1021-33 CODEN: CELLB5;ISSN: 0092-8674, 1992, XP002090186 *
See also references of WO9507094A1 *
SINNIS, PHOTINI ET AL: "Structural and functional properties of region II-plus of the malaria circumsporozoite protein", J. EXP. MED. (1994), 180(1), 297-306 CODEN: JEMEAV;ISSN: 0022-1007, 1994, XP002090187 *

Also Published As

Publication number Publication date
WO1995007094A1 (en) 1995-03-16
EP0730466A1 (en) 1996-09-11
AU7724894A (en) 1995-03-27
CA2171562A1 (en) 1995-03-16

Similar Documents

Publication Publication Date Title
EP0716603A4 (en) Methods and compositions for inhibiting uridine secretion
GB2294465A8 (en) Perfluoroelastomeric compositions and methods
HU9503088D0 (en) Erythropoietin analog compositions and methods
GB9410246D0 (en) Processing stabiliser composition
ZA942052B (en) Tricritical point composition
KR950013580B1 (en) Method and compositions for difusion patierning
EP0734398A4 (en) Compounds and methods
AU5130793A (en) Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
IL109036A0 (en) Method and compositions for disrupting the epithelial barrier function
GB9307449D0 (en) Surfactant composition
EP0730466A4 (en) Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
ZA919577B (en) Composition and method for preventing fluorosis
GB2274656B (en) Alloying additive
GB9224295D0 (en) Method and composition
GB2274650B (en) Composition for skin barrier
AU1378495A (en) Methods and compositions for inhibiting thrombogenesis
ZA946967B (en) Lyophillisate composition
GB9417430D0 (en) Composition
GB9320370D0 (en) Frit-containing composition
GB9204445D0 (en) Switching arrangement and method
GB9308051D0 (en) Method and composition
GB9117725D0 (en) Skin-care composition and method
GB9321025D0 (en) Antimalarial compositions and method
GB9313100D0 (en) Lockable casement stay
GB9111824D0 (en) Method and composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960410

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK ES FR GB IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990225

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE DK ES FR GB IT LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000331